Variability in the association between long-term exposure to ambient air pollution and mortality by exposure assessment method and covariate adjustment: A census-based country-wide cohort study.

Cause-specific mortality Environmental hazard Exposure assessment Health effects Population-based Survival analysis

Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
15 Jan 2022
Historique:
received: 25 04 2021
revised: 02 08 2021
accepted: 29 08 2021
pubmed: 14 9 2021
medline: 20 11 2021
entrez: 13 9 2021
Statut: ppublish

Résumé

Ambient air pollution exposure has been associated with higher mortality risk in numerous studies. We assessed potential variability in the magnitude of this association for non-accidental, cardiovascular disease, respiratory disease, and lung cancer mortality in a country-wide administrative cohort by exposure assessment method and by adjustment for geographic subdivisions. We used the Belgian 2001 census linked to population and mortality register including nearly 5.5 million adults aged ≥30 (mean follow-up: 9.97 years). Annual mean concentrations for fine particulate matter (PM We found no consistent differences between both exposure methods. We observed most robust associations with lung cancer mortality. Hazard Ratios (HRs) per 10 μg/m Long-term air pollution exposure was associated with higher lung cancer mortality risk but not consistently with the other studied causes. Magnitude of associations varied by adjustment for geographic subdivisions, area-level socio-economic covariates and less by exposure assessment method.

Sections du résumé

BACKGROUND BACKGROUND
Ambient air pollution exposure has been associated with higher mortality risk in numerous studies. We assessed potential variability in the magnitude of this association for non-accidental, cardiovascular disease, respiratory disease, and lung cancer mortality in a country-wide administrative cohort by exposure assessment method and by adjustment for geographic subdivisions.
METHODS METHODS
We used the Belgian 2001 census linked to population and mortality register including nearly 5.5 million adults aged ≥30 (mean follow-up: 9.97 years). Annual mean concentrations for fine particulate matter (PM
RESULTS RESULTS
We found no consistent differences between both exposure methods. We observed most robust associations with lung cancer mortality. Hazard Ratios (HRs) per 10 μg/m
CONCLUSION CONCLUSIONS
Long-term air pollution exposure was associated with higher lung cancer mortality risk but not consistently with the other studied causes. Magnitude of associations varied by adjustment for geographic subdivisions, area-level socio-economic covariates and less by exposure assessment method.

Identifiants

pubmed: 34517316
pii: S0048-9697(21)05166-4
doi: 10.1016/j.scitotenv.2021.150091
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

150091

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mariska Bauwelinck (M)

Interface Demography, Department of Sociology, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: mariska.bauwelinck@vub.be.

Jie Chen (J)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: j.chen1@uu.nl.

Kees de Hoogh (K)

Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: c.dehoogh@swisstph.ch.

Klea Katsouyanni (K)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Environmental Research Group Imperial College, London, London, UK. Electronic address: kkatsouy@med.uoa.gr.

Sophia Rodopoulou (S)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: srodopoyl@med.uoa.gr.

Evangelia Samoli (E)

Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: esamoli@med.uoa.gr.

Zorana J Andersen (ZJ)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Electronic address: vlq961@sund.ku.dk.

Richard Atkinson (R)

Population Health Research, Institute St George's, University of London, London, UK. Electronic address: atkinson@sgul.ac.uk.

Lidia Casas (L)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Medical Sociology and Health Policy, Department of Epidemiology and Social Medicine, University of Antwerp, Wilrijk, Belgium. Electronic address: Lidia.CasasRuiz@uantwerpen.be.

Patrick Deboosere (P)

Interface Demography, Department of Sociology, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: patrick.deboosere@vub.be.

Claire Demoury (C)

Risk and Health Impact Assessment Unit, Sciensano, Brussels, Belgium. Electronic address: Claire.Demoury@sciensano.be.

Nicole Janssen (N)

National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: nicole.janssen@rivm.nl.

Jochem O Klompmaker (JO)

National Institute for Public Health and the Environment, Bilthoven, the Netherlands; Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: jklompmaker@hsph.harvard.edu.

Wouter Lefebvre (W)

Vlaamse Instelling voor Technologisch Onderzoek (VITO), Mol, Belgium. Electronic address: wouter.lefebvre@vito.be.

Amar Jayant Mehta (AJ)

Department of Public Health, University of Copenhagen, Copenhagen, Denmark. Electronic address: amar.mehta@sund.ku.dk.

Tim S Nawrot (TS)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Centre for Environmental Sciences, University of Hasselt, Diepenbeek, Belgium. Electronic address: tim.nawrot@uhasselt.be.

Bente Oftedal (B)

Department of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: BenteMargaret.Oftedal@fhi.no.

Matteo Renzi (M)

Department of Epidemiology, Lazio Region Health Service, ASL Roma 1, Rome, Italy. Electronic address: m.renzi@deplazio.it.

Massimo Stafoggia (M)

Department of Epidemiology, Lazio Region Health Service, ASL Roma 1, Rome, Italy; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: m.stafoggia@deplazio.it.

Maciek Strak (M)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands; National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: maciek.strak@rivm.nl.

Hadewijch Vandenheede (H)

Interface Demography, Department of Sociology, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: hadewijch.vandenheede@vub.be.

Charlotte Vanpoucke (C)

Belgian Interregional Environment Agency (IRCEL-CELINE), Brussel, Belgium. Electronic address: vanpoucke@irceline.be.

An Van Nieuwenhuyse (A)

Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium; Risk and Health Impact Assessment Unit, Sciensano, Brussels, Belgium. Electronic address: An.vanNieuwenhuyse@lns.etat.lu.

Danielle Vienneau (D)

Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: danielle.vienneau@swisstph.ch.

Bert Brunekreef (B)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: B.Brunekreef@uu.nl.

Gerard Hoek (G)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands. Electronic address: g.hoek@uu.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH